ESMO: Novartis posts data from failed spartalizumab phase 3, reaffirms commitment to PD-1 combos

ESMO: Novartis posts data from failed spartalizumab phase 3, reaffirms commitment to PD-1 combos
ntaylor
Fri, 09/18/2020 – 11:36

Published on Fri, 18 Sep 2020 15:36:55 +0000 and brought to you by salesforce filter collection